Axsome Therapeutics' GAAP loss for 2020 was $102.901 million, up 50.6% from $68.345 million the previous year.
Axsome Therapeutics' GAAP loss for 2020 was $102.901 million, up 50.6% from $68.345 million the previous year.
Financial results
Axsome Therapeutics' GAAP loss for 2020 was $102.901 million, up 50.6% from $68.345 million the previous year. 
axsometherapeuticsinc.gcs-web.com News feed
English (US) 